↓ Skip to main content

Medical treatment versus “Watch and Wait” in the clinical management of CE3b echinococcal cysts of the liver

Overview of attention for article published in BMC Infectious Diseases, September 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Medical treatment versus “Watch and Wait” in the clinical management of CE3b echinococcal cysts of the liver
Published in
BMC Infectious Diseases, September 2014
DOI 10.1186/1471-2334-14-492
Pubmed ID
Authors

Francesca Rinaldi, Annalisa De Silvestri, Francesca Tamarozzi, Federico Cattaneo, Raffaella Lissandrin, Enrico Brunetti

Abstract

Available treatments for uncomplicated hepatic cystic echinococcosis (CE) include surgery, medical therapy with albendazole (ABZ), percutaneous interventions and the watch-and-wait (WW) approach. Current guidelines indicate that patients with hepatic CE should be assigned to each option based on cyst stage and size, and patient characteristics. However, treatment indications for transitional CE3b cysts are still uncertain. These cysts are the least responsive to non-surgical treatment and often present as indolent, asymptomatic lesions that may not warrant surgery unless complicated. Evidence supporting indications for treatment of this stage is lacking. In the attempt to fill this gap before the implementation of randomized clinical trials, we compared the clinical behavior of single hepatic CE3b cysts in 60 patients followed at the WHO Collaborating Centre for Cystic Echinococcosis of the University of Pavia.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 17%
Researcher 6 15%
Student > Doctoral Student 6 15%
Student > Bachelor 5 12%
Student > Postgraduate 3 7%
Other 8 20%
Unknown 6 15%
Readers by discipline Count As %
Medicine and Dentistry 26 63%
Immunology and Microbiology 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Social Sciences 1 2%
Business, Management and Accounting 1 2%
Other 0 0%
Unknown 8 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2014.
All research outputs
#20,236,620
of 22,763,032 outputs
Outputs from BMC Infectious Diseases
#6,456
of 7,666 outputs
Outputs of similar age
#199,994
of 238,632 outputs
Outputs of similar age from BMC Infectious Diseases
#127
of 151 outputs
Altmetric has tracked 22,763,032 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,666 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,632 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 151 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.